Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley R Riddell

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
The Journal of Experimental Medicine|December 22, 2004
Finding a place for tumor-specific T cells in targeted cancer therapyStanley R Riddell
Hematology. American Society of Hematology. Education Program|November 21, 2007
Engineering antitumor immunity by T-cell adoptive immunotherapyStanley R Riddell
Blood Cancer Discovery|October 18, 2021
Dual Targeting with CAR T Cells to Limit Antigen Escape in Multiple MyelomaSylvain Simon, Stanley R Riddell
Immunology and Cell Biology|February 9, 2011
Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemiaMarie Bleakley, Stanley R Riddell
Trends in Immunology|July 15, 2015
Engineering CAR-T cells: Design conceptsShivani Srivastava, Stanley R Riddell
Journal of Immunology (Baltimore, Md. : 1950)|January 10, 2018
Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside EfficacyShivani Srivastava, Stanley R Riddell
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Artificial antigen-presenting cells for use in adoptive immunotherapyCameron J Turtle, Stanley R Riddell
Current Opinion in Immunology|January 27, 2015
Designing chimeric antigen receptors to effectively and safely target tumorsMichael C Jensen, Stanley R Riddell
Current Opinion in Immunology|January 18, 2011
Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapyCameron J Turtle, Stanley R Riddell
Immunological Reviews|December 17, 2013
Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cellsMichael C Jensen, Stanley R Riddell
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
The Journal of Experimental Medicine|December 22, 2004
Finding a place for tumor-specific T cells in targeted cancer therapyStanley R Riddell
Hematology. American Society of Hematology. Education Program|November 21, 2007
Engineering antitumor immunity by T-cell adoptive immunotherapyStanley R Riddell
Blood Cancer Discovery|October 18, 2021
Dual Targeting with CAR T Cells to Limit Antigen Escape in Multiple MyelomaSylvain Simon, Stanley R Riddell
Immunology and Cell Biology|February 9, 2011
Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemiaMarie Bleakley, Stanley R Riddell
Trends in Immunology|July 15, 2015
Engineering CAR-T cells: Design conceptsShivani Srivastava, Stanley R Riddell
Journal of Immunology (Baltimore, Md. : 1950)|January 10, 2018
Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside EfficacyShivani Srivastava, Stanley R Riddell
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Artificial antigen-presenting cells for use in adoptive immunotherapyCameron J Turtle, Stanley R Riddell
Current Opinion in Immunology|January 27, 2015
Designing chimeric antigen receptors to effectively and safely target tumorsMichael C Jensen, Stanley R Riddell
Current Opinion in Immunology|January 18, 2011
Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapyCameron J Turtle, Stanley R Riddell
Immunological Reviews|December 17, 2013
Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cellsMichael C Jensen, Stanley R Riddell
Pageof 18